From 1925 to 1948, Yellapragada SubbaRow conducted groundbreaking medical research at Harvard and Lederle Laboratories. He made several foundational discoveries, including identifying ATP as the energy molecule of cells and synthesizing folic acid at an industrial scale, which made prenatal care widely available to prevent neural tube defects. His laboratory also developed Aureomycin, the first broad-spectrum oral antibiotic, and methotrexate, the first drug to induce remission in childhood leukemia. Despite his massive contributions to medicine, SubbaRow never received a tenured faculty position and his name was not put on his drugs.
